ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000228.1|Granaticin_1 # 18 # 767 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000228.1|Granaticin_1 	18	767	-	Loose	450	29.261	TUS-1	50.0	3000844	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	TUS beta-lactamase	ATGGCCACCGACGCGCCCGAGGCGCCTGTCGCCCTGGTCACCGGTTCCTCCTCCGGCATCGGGCAGACCGTCGCCCAGCGGCTGGCCGCCGAGGGGTACCGGGTGGTCGTCAACTCGGCCCGCTCCGTGGAGGACGGCGAGAAGACGGCCGCCGCACTGCCCGACGCGCTCTACGTCCGGGCGGACGTCTCCGAGGAGGCGGACGCCCGCCGTCTGGTGGACACCGCCGTGGAGCACTACGGCCGACTGGACGTCCTCGTCAACAACGCCGGCCGGACCCGCGCCATCCCGCACGCCGACCTGGCGGCCGCCACCCCCGAGGTGTGGCGGGAGATCCTCGGTCTGAACGTCATCGGCACCTGGCAGACCACCGTCGCCGCGATGCCTCACCTCGCCCGCTCGGGGAACGGCTCCGTCGTCAACGTGTCGTCGATCGCGGGGAGCCGCCCGGCCGGCAGCTCGATCCCTTACGCGGTGAGCAATGGCGGCCATCGAGCACAGACTCGGCTCCTCGCCAACACGGTGGGTCCGGCTGTGCGCGTCAACGCGGTCGCGCCGGGGCTGATCGAGACGCCGTGGACGCAGAACAGCGACTTCTTCGCACCGATCGCCGAGCACGTGCGGCAGACGACGCCACTGCGCCGGACAGGCAGGCCGGAAGACGTCGCGGAAGCCGTCCTCGGGCTGGTCCGCGCCACGTACACCACCGGGCAGGTCCTGCTCGTGGACGGCGGCGCCCACCTCCTCTGA	MATDAPEAPVALVTGSSSGIGQTVAQRLAAEGYRVVVNSARSVEDGEKTAAALPDALYVRADVSEEADARRLVDTAVEHYGRLDVLVNNAGRTRAIPHADLAAATPEVWREILGLNVIGTWQTTVAAMPHLARSGNGSVVNVSSIAGSRPAGSSIPYAVSNGGHRAQTRLLANTVGPAVRVNAVAPGLIETPWTQNSDFFAPIAEHVRQTTPLRRTGRPEDVAEAVLGLVRATYTTGQVLLVDGGAHLL	MYHYFSSLFVLIFSTLVYPQSDKLKIEPLNDHMYVYTTYQVFQGVEYSSNALYVVTDEGVILIDTPWDKDQYAPLVEHIRREHNKEIKWVITTHFHEDRSGGLDYFNKAGAETYTYALTNEILKQRNEPQATFTFGSTKQFNLGKEKIEVYFLGEGHSKDNTVVWFPEEAILYGGCLIKSAEATTIGNIVDGNVEAWPTTIKAVKRKFKKAKVIIPGHDAWNQSGHLENTARILSAYQAQKLKNNKQL	100.40	gnl|BL_ORD_ID|449|hsp_num:0	392			183	243	amoxicillin; piperacillin; ticarcillin
BGC0000228.1|Granaticin_2 # 767 # 1585 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.719	BGC0000228.1|Granaticin_2 	767	1585	-	Loose	600	25.0238	Mrx	25.0	3003839	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGACGACGGCGACAGCGACGGCCACGGCCACCCCCGGCACGGCGGCGAAGCCGGTGGCGCTGGTGACCGGTGCCACCAGCGGCATCGGGCTTGCGATCGCCCGCCGGCTGGCCGCGCTCGGCGCGCGCACCTTCCTGTGCGCCCGGGACGAGGAGCGGCTGGCGCAGACGGTGAAGGAGCTGCGCGGCGAGGGGTTCGACGTCGACGGCACGGTGTGCGACGTGGCGGATCCGGCCCAGATCCGCGCCTACGTGGCGGCGGCCGTCCAGCGGTACGGCACGGTCGACATCCTGGTGAACAACGCCGGCCGCAGCGGCGGCGGCGCCACCGCCGAAATCGCCGACGAGCTCTGGCTCGACGTCATCACCACCAACCTGACCAGCGTCTTCCTCATGACGAAGGAAGTGCTCAACGCGGGCGGGATGCTCGCCAAGAAGCGTGGGCGGATCATCAACATCGCCTCCACCGGCGGCAAGCAGGGCGTCGTGCACGCGGTGCCGTACTCGGCGTCCAAGCACGGCGTCGTCGGGCTGACCAAGGCCCTCGGCCTGGAGCTGGCCCGTACCGGCATCACCGTGAACGCGGTGTGCCCGGGCTTCGTGGAGACCCCGATGGCCGAGCGGGTGCGCGAGCACTACGCGGGCATCTGGCAGGTCTCCGAGGAGGAGACGTTCGACCGCATCACCAACCGGGTGCCGCTGGGCCGGTACGTGGAGACCCGCGAGGTGGCCGCGATGGTCGAGTACCTGGTGGCGGACGACGCGGCGGCGGTCACCGCGCAGGCGCTGAACGTCTGCGGCGGGCTGGGCAACTACTGA	MTTATATATATPGTAAKPVALVTGATSGIGLAIARRLAALGARTFLCARDEERLAQTVKELRGEGFDVDGTVCDVADPAQIRAYVAAAVQRYGTVDILVNNAGRSGGGATAEIADELWLDVITTNLTSVFLMTKEVLNAGGMLAKKRGRIINIASTGGKQGVVHAVPYSASKHGVVGLTKALGLELARTGITVNAVCPGFVETPMAERVREHYAGIWQVSEEETFDRITNRVPLGRYVETREVAAMVEYLVADDAAAVTAQALNVCGGLGNY	MSERRYSPLATLFAATFLFRIGNAVAALALPWFVLSHTKSAAWAGATAASSVIATIIGAWVGGGLVDRFGRAPVALISGVVGGVAMASIPLLDAVGALSNTGLIACVVLGAAFDAPGMAAQDSELPKLGHVAGLSVERVSSLKAVIGNVAILGGPALGGAAIGLLGAAPTLGLTAFCSVLAGLLGAWVLPARAARTMTTTATLSMRAGVAFLWSEPLLRPLFGIVMIFVGIVGANGSVIMPALFVDAGRQVAELGLFSSMMGAGGLLGIAIHASVGARISAQNWLAVAFCGSAVGSLLLSQLPGVPVLMLLGALVGLLTGSVSPILNAAIYNRTPPELLGRVLGTVSAVMLSASPMVMLAAGAFVDLAGPLPGLVVSAVFAGLVALLSLRLQFATMAAAATASAPTHTEGEH	66.02	gnl|BL_ORD_ID|4923|hsp_num:0	5917			216	468	
BGC0000228.1|Granaticin_3 # 1854 # 3119 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0000228.1|Granaticin_3 	1854	3119	+	Loose	750	176.792	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.63	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGACCCGACGCGTAGTGATCACCGGGGTCGGGGTGCGTGCCCCTGGCGGCTCAGGGACGAAGGAGTTCTGGGACCTGCTCACCGCCGGCCGCACGGCGACTCGACCCATCAGTTTCTTCGACGCCTCCCCGTTCCGCTCGCGGATCGCGGGGGAGATCGACTTCGACGCCGTCGCGGAGGGCTTCTCCCCGCGTGAGGTCCGTCGCATGGACCGCGCCACCCAGTTCGCGGTCGCCTGCACCCGGGACGCGCTGGCCGACAGCGGCCTGGACACGGGCGCCCTCGACCCGTCCCGGATCGGCGTCGCCCTGGGGAGCGCGGTCGCGTCGGCGACGAGCCTGGAGAACGAGTACCTGGTGATGTCGGACTCCGGCCGCGAGTGGCTGGTGGACCCGGCACACCTGTCGCCGATGATGTTCGACTACCTCAGCCCGGGCGTCATGCCCGCCGAGGTCGCCTGGGCGGCCGGCGCGGAGGGCCCGGTCACCATGGTCTCCGACGGCTGCACCTCGGGCCTGGACTCGGTCGGCTACGCCGTTCAGGGGACCCGCGAGGGCAGCGCGGACGTGGTGGTCGCCGGCGCCGCCGACACCCCCGTCTCCCCGATCGTGGTGGCCTGCTTCGACGCCATCAAGGCGACGACCCCGCGCAACGACGACCCGGCGCACGCCTCCCGGCCCTTCGACGGCACCCGCAACGGCTTCGTCCTCGCCGAGGGCGCCGCCATGTTCGTCCTGGAGGAGTACGAGGCCGCCCAGCGACGCGGAGCCCACATCTACGCCGAGGTCGGCGGCTACGCCACGCGCTCGCAAGCGTACCACATGACGGGTCTGAAGAAGGACGGCCGGGAGATGGCCGAATCGATCAGGGCCGCACTCGACGAGGCCCGGCTGGACCGTACGGCGGTCGACTACGTCAACGCGCACGGCTCCGGCACCAAGCAGAACGACCGCCACGAGACGGCCGCCTTCAAGCGCAGCCTCGGCGAGCACGCGTACGCGGTGCCCGTCAGCTCCATCAAATCCATGGGGGGGCACTCACTCGGCGCGATCGGCTCCATCGAGATCGCAGCGTCGGTCCTCGCCATCGAACACAACGTCGTCCCGCCGACGGCGAATCTGCACACCCCCGACCCCGAGTGCGACCTGGACTACGTTCCGCTCACCGCGCGCGAGCAGCGCGTCGACACGGTGCTCACCGTGGGCAGCGGCTTCGGCGGGTTCCAGAGCGCCATGGTCCTGCACCGCCCGGAGGAGGCCGCGTGA	MTRRVVITGVGVRAPGGSGTKEFWDLLTAGRTATRPISFFDASPFRSRIAGEIDFDAVAEGFSPREVRRMDRATQFAVACTRDALADSGLDTGALDPSRIGVALGSAVASATSLENEYLVMSDSGREWLVDPAHLSPMMFDYLSPGVMPAEVAWAAGAEGPVTMVSDGCTSGLDSVGYAVQGTREGSADVVVAGAADTPVSPIVVACFDAIKATTPRNDDPAHASRPFDGTRNGFVLAEGAAMFVLEEYEAAQRRGAHIYAEVGGYATRSQAYHMTGLKKDGREMAESIRAALDEARLDRTAVDYVNAHGSGTKQNDRHETAAFKRSLGEHAYAVPVSSIKSMGGHSLGAIGSIEIAASVLAIEHNVVPPTANLHTPDPECDLDYVPLTAREQRVDTVLTVGSGFGGFQSAMVLHRPEEAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.20	gnl|BL_ORD_ID|1968|hsp_num:0	1943			96	1245	isoniazid
BGC0000228.1|Granaticin_4 # 3116 # 4363 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.755	BGC0000228.1|Granaticin_4 	3116	4363	+	Loose	700	27.335	tet(D)	31.43	3000168	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGCACCCCTGACCGCCGGCGGGCCGTCGTCACCGGCCTCAGCGTCGCCGCCCCCGGTGGCCTCGGCACCGAGCGTTACTGGAAGTCCCTGCTGACCGGCGAGAACGGCATCGCCGAGCTCTCCCGCTTCGACGCCTCCCGCTACCCGTCCCGACTGGCCGGGCAGATCGACGACTTCGAGGCCTCCGAGCACCTGCCCAGCAGGCTGCTGCCGCAGACCGACGTCTCCACGCGCTACGCGCTGGCCGCCGCCGACTGGGCGCTCGCCGACGCGGGCGTCGGCCCCGAGTCGGGCCTCGACGACTACGACCTGGGCGTCGTCACCTCCACCGCCCAGGGCGGCTTCGACTTCACCCACCGAGAGTTCCACAAGCTGTGGAGCCAGGGACCCGCGTACGTCAGCGTGTACGAGTCCTTCGCCTGGTTCTACGCCGTCAACACCGGCCAGATCTCCATCCGCAACACGATGCGCGGCCCCAGCGCCGCCCTGGTCGGCGAACAGGCCGGCGGCCTCGACGCGATCGGGCACGCCCGGCGTACGGTCCGCCGCGGACCCGGCTGGTGCTCAGCGGTGGCGTCGACTCGGCGCTCGACCCGTGGGGCTTCGTCCTCGCAGCTCTCCGGCGGTCTCGTCTCCACGGTCGCCGACCCGGAGCGCGCCTATCTGCCCTTCGACGTCGACGCCTCCGGCTACGTGCCGGGCGAAGGCGGCGCCGTCCTCATCGTCGAGGACGCCGACTCGGCGCGCGCACGGGGTGCCGAGCGGATCTACGTGAGATCGCCGCTACGCCGCGACCCGGCACCCGGCTCCGGCCGTCCGCCCGCCCTCGGCCGCGCCGCCGAACTCGCCCTCGCCGAAGCGGGGCTGACGCCCGCCGACATCTCGGTGGTGTTCGCCGACGGAGCGGGGGTCCCGGAGCTCGACCGCGCCGAGGCCGACACCCTCGCCCGGCTCTTCGGGCCGCGGGGCGTCCCGGTGACCGCGCCCAAGGCACTCACCGGCCGCCTGTGCGCCGGTGGCGGCCCCGCCGACCTGGCGGCCGCGCTGCTCGCCCTGCGCGACCAGGTGATCCCCGCGACCGGCCGCCACCGCGCGGTGCCGGACGCCTACGCCCTCGACCTGGTGACCGGCCGGCCCCGCGAGGCCGCCCTGAGCGCGGCCCTCGTCCTCGCGCGCGGCCGCCACGGCTTCAACTCCGCGGTCGTCGTCACGCTCCGCGGCTCTGACCACCGTCGGCCCACCTGA	MSTPDRRRAVVTGLSVAAPGGLGTERYWKSLLTGENGIAELSRFDASRYPSRLAGQIDDFEASEHLPSRLLPQTDVSTRYALAAADWALADAGVGPESGLDDYDLGVVTSTAQGGFDFTHREFHKLWSQGPAYVSVYESFAWFYAVNTGQISIRNTMRGPSAALVGEQAGGLDAIGHARRTVRRGPGWCSAVASTRRSTRGASSSQLSGGLVSTVADPERAYLPFDVDASGYVPGEGGAVLIVEDADSARARGAERIYVRSPLRRDPAPGSGRPPALGRAAELALAEAGLTPADISVVFADGAGVPELDRAEADTLARLFGPRGVPVTAPKALTGRLCAGGGPADLAAALLALRDQVIPATGRHRAVPDAYALDLVTGRPREAALSAALVLARGRHGFNSAVVVTLRGSDHRRPT	MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPLLGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVADSTAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFKPAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWDSAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVYPVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQSADGTVWLIGTALYGLLLAICLLIRKPAPVAATC	105.33	gnl|BL_ORD_ID|1187|hsp_num:0	1138			75	285	tetracycline
BGC0000228.1|Granaticin_5 # 4445 # 4702 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.698	BGC0000228.1|Granaticin_5 	4445	4702	+	Loose	450	22.3274	rmtH	38.1	3003198	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGGCTCGGCTCACCCTCGACGGACTGCGCACCATCCTCGTCGCCTGCGCCGGAGAGGACGACGGCGTCGACCTCTCCGGCGACATCCTCGACATCACGTTCGAGGAGCTCGGCTACGACTCCCTCGCCCTCATGGAGAGCGCCTCCCGCATCGAGCGCGAGCTCGGAGTCGCCCTCGCCGACGGTGACATCAACGAGGAGCTGACCCCCCGCGTCCTCCTCGACCTCGTCAACGGCGCCCAGGCCGAGGCGGCCTGA	MARLTLDGLRTILVACAGEDDGVDLSGDILDITFEELGYDSLALMESASRIERELGVALADGDINEELTPRVLLDLVNGAQAEAA	MTIEQAAADILSSKKYQLLCPDTVVRILTQEWGRHKKPKQAVERTRERLHGICGAYLAPQVEKQASTALAAGDVQKALALHASTRERLDTYPQLYQFVFENNLPARVLDIACGLNPLMLHRQGVASVWGCDIHQGLGNVLTPYAQKHGWDFTFALHDVLCAPVAASGDMALVFKLLPLLEREQPGAALALLRTLDAPVICVSFPTRSLGGRGKGMHQHYATWFEGLVAPHFTVQHHTLIGDELLYRIQPNPA	33.73	gnl|BL_ORD_ID|33|hsp_num:0	41			171	234	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000228.1|Granaticin_6 # 4822 # 5796 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.744	BGC0000228.1|Granaticin_6 	4822	5796	+	Loose	300	25.7942	dfrA14	36.36	3002859	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGTCCAGCCCGCCGCCACCCCCGTCTCCCTGCCCAGCCCCACCGTCCACCGCAGCGAGCACACCGTGACGGTGGCCGCACCGCCCGAGGCGCTCTACGCGCTCGTCGCCGACGTGACGCGGTGGCCGGCCGTGTTCGAGCCGACGGTGCACGTGCGGCACCTCGCCCGGGAGGGGCGGACCGAACGGTTCGAGATCTGGGCCGAGGTGAACGGCGAGATCGCGCACTGGCGTTCGCGCCGCGTTCTCGACCCGGTGCGGCGGTACGTGTCGTTCCGTCAGGAGCACAGCCGGCCGCCGGTGACCTCGATGTCCGGAGGGTGGCTGTTCCGCCCGCTGGCCGACGGCCGGACGGAGATCGTGCTGCGGCACCGGTTCACCGTCGCCGACGACGACCCGGCCGCCGTGGCCCGTATCGAGGAGGCCCTCGACCGCAACAGCGCCCGAGAACTGGGCGCGCTCGCGGCGCTCGCCGAGACCGGGCACCCGGTGGACGAACTGGTCTTCTCCTTCACGGACACCCTCCCGCTCCAGGGCGCCGCCCGGGACGCGTACACCTTCGTCGAGCGTGCCGAGCGCTGGGCCGAGCTGCTGCCGCACGTCGCCCAATGTGGTGCTGACCGAGCCGGAACCGGGCTCGAGCAGTGGCTGGAGATGGACACCGTGACGGCCGACGGGTCCACCCACACCACCAGGTCGGCGCGCATCTGCCGGGCGCCCGAGTGGATCGCGTACAACGAGCAGCGCACCCCCCGGCTCGTGTCCGGCCACAGCGGCGAGTGGACGTTCGCCCAGACCCCCGAGGGTCCCGTGGCGACCGCCCGCCACACCGTCGCCGTCGACCCGAGCGGCATCACCGAGGTCCTCGGCCCGGACGCCACCCTCGCCGACGCCCGGGCCTACCTCCGCGACGCCCTGGGCCGCAACAGCCTGGCCACGCTGCGGCACGCCGCCGAAGCGGCCCAGCGGGCGTAG	MVQPAATPVSLPSPTVHRSEHTVTVAAPPEALYALVADVTRWPAVFEPTVHVRHLAREGRTERFEIWAEVNGEIAHWRSRRVLDPVRRYVSFRQEHSRPPVTSMSGGWLFRPLADGRTEIVLRHRFTVADDDPAAVARIEEALDRNSARELGALAALAETGHPVDELVFSFTDTLPLQGAARDAYTFVERAERWAELLPHVAQCGADRAGTGLEQWLEMDTVTADGSTHTTRSARICRAPEWIAYNEQRTPRLVSGHSGEWTFAQTPEGPVATARHTVAVDPSGITEVLGPDATLADARAYLRDALGRNSLATLRHAAEAAQRA	MKVSLMAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYAVVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDIEPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG	206.37	gnl|BL_ORD_ID|1457|hsp_num:0	1592			159	258	trimethoprim
